Reduced GFAP and SNAP25 in ex-forwards has an uncertain basis, while elevated p-tau-<sub>181</sub> more so than p-tau<sub>217</sub> points towards non-AD tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.